ABEO
ABEONA THERAPEUTICS INC.
NASDAQ · Healthcare · Biotechnology · US
$5.57
−0.36%Next report
Analyst consensus
- Next report date
- Nov 11, 2026
- EPS estimate
- -$0.14
- Revenue estimate
- $16.5M
Latest reported
- Last report date
- Aug 13, 2026
- EPS actual
- -$0.35
- EPS estimate
- -$0.23
- Revenue actual
- $11.4M
- Revenue estimate
- $12.2M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 9
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +6.1%
- Revenue beats (12Q)
- 1
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $23
- PT range
- $17 – $30
- Analysts
- 3
3 Buy0 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 13, 2026 | -$0.23 | -$0.35 | Miss -51.08% | $11.4M |
| May 13, 2026 | -$0.33 | -$0.30 | Beat 9.09% | $8.7M |
| Mar 17, 2026 | -$0.35 | -$0.34 | Beat 3.41% | $5.4M |
| Nov 12, 2025 | -$0.27 | -$0.10 | Beat 62.96% | — |
| Aug 14, 2025 | -$0.39 | $1.71 | Beat 538.46% | $400.0K |
| May 15, 2025 | -$0.35 | -$0.24 | Beat 31.43% | — |
| Mar 20, 2025 | -$0.43 | -$0.24 | Beat 44.19% | — |
| Nov 14, 2024 | -$0.38 | -$0.31 | Beat 18.42% | — |
| May 15, 2024 | -$0.47 | -$0.53 | Miss -12.77% | — |
| Mar 18, 2024 | -$0.51 | -$0.64 | Miss -25.49% | $2.8M |
| Nov 13, 2023 | -$0.53 | -$0.48 | Beat 9.43% | — |
| May 11, 2023 | -$0.58 | -$0.54 | Beat 6.90% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 11, 2026